Prevalence of and risk factors for substance use among perinatally human immunodeficiency virus-infected and perinatally exposed but uninfected youth
about
Elevated aspartate aminotransferase-to-platelet ratio index in perinatally HIV-infected children in the United StatesProfiles of Risk Among HIV-Infected Youth in Clinic SettingsThe Burden of Oral Disease among Perinatally HIV-Infected and HIV-Exposed Uninfected Youth.Following young people with perinatal HIV infection from adolescence into adulthood: the protocol for PHACS AMP Up, a prospective cohort study.Marijuana Use and Psychiatric Disorders in Perinatally HIV-Exposed Youth: Does HIV Matter?Prevalence and correlates of substance use among youth living with HIV in clinical settings.The Oral HIV/AIDS Research Alliance Program: lessons learned and future directions.Lower total and regional grey matter brain volumes in youth with perinatally-acquired HIV infection: Associations with HIV disease severity, substance use, and cognition.Contributions of Disease Severity, Psychosocial Factors, and Cognition to Behavioral Functioning in US Youth Perinatally Exposed to HIV.Changes in Substance Use Symptoms Across Adolescence in Youth Perinatally Infected with HIV.Prospective memory in youth with perinatally-acquired HIV infection.Deformed Subcortical Structures Are Related to Past HIV Disease Severity in Youth With Perinatally Acquired HIV Infection.Oral Human Papillomavirus in Youth From the Pediatric HIV/AIDS Cohort Study.Oral microbiota in youth with perinatally acquired HIV infection.
P2860
Q34200171-F1AB2AF3-8840-405D-9ACE-9698994C248DQ35079623-D257B28E-8BD2-41CE-862E-DC380E7F33D0Q36051717-436028B5-5466-45E6-8806-E239AE2645C7Q37007002-F24D4545-463A-4B2F-BF75-F981AD198656Q37237652-7E01EA35-A29D-4F2D-AC21-32264D23FC2CQ37478571-8D103473-4824-44A7-BD8F-AE59E7B89629Q38381125-F857F639-3354-4BBD-9D2F-60A9FEC946C8Q38770217-AD2B2F17-88AD-462A-A813-85522ED7DCB5Q39541645-E66AAE79-71D2-426E-8833-7C587A465C3AQ39637430-172A529F-38A8-4251-BD11-C71DBB75DC6AQ40104355-A4FB42D7-FAE0-465C-AD85-F8B08097EDD7Q40447357-B7ADADFC-5615-4538-9E37-B7C7FEE650B5Q40613499-A298C34A-3156-402E-AE51-235BDB797026Q55014734-F712823F-564F-4874-B060-A54207831ACA
P2860
Prevalence of and risk factors for substance use among perinatally human immunodeficiency virus-infected and perinatally exposed but uninfected youth
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
Prevalence of and risk factors ...... y exposed but uninfected youth
@ast
Prevalence of and risk factors ...... y exposed but uninfected youth
@en
type
label
Prevalence of and risk factors ...... y exposed but uninfected youth
@ast
Prevalence of and risk factors ...... y exposed but uninfected youth
@en
prefLabel
Prevalence of and risk factors ...... y exposed but uninfected youth
@ast
Prevalence of and risk factors ...... y exposed but uninfected youth
@en
P2093
P2860
P1476
Prevalence of and risk factors ...... y exposed but uninfected youth
@en
P2093
Anna-Barbara Moscicki
Deborah Kacanek
George R Seage
Julie Alperen
Katherine Tassiopoulos
Renee Smith
Sean Brummel
P2860
P304
P356
10.1016/J.JADOHEALTH.2013.09.003
P577
2013-11-13T00:00:00Z